161 related articles for article (PubMed ID: 24323972)
21. Simultaneous determination of vinblastine and its monomeric precursors vindoline and catharanthine in Catharanthus roseus by capillary electrophoresis-mass spectrometry.
Chen Q; Li N; Zhang W; Chen J; Chen Z
J Sep Sci; 2011 Oct; 34(20):2885-92. PubMed ID: 21735550
[TBL] [Abstract][Full Text] [Related]
22. Rapid and simultaneous determination of five vinca alkaloids in Catharanthus roseus and human serum using trilinear component modeling of liquid chromatography-diode array detection data.
Liu Z; Wu HL; Li Y; Gu HW; Yin XL; Xie LX; Yu RQ
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():114-123. PubMed ID: 26321366
[TBL] [Abstract][Full Text] [Related]
23. Attempted Synthesis of
Keglevich A; Mayer S; Pápai R; Szigetvári Á; Sánta Z; Dékány M; Szántay C; Keglevich P; Hazai L
Molecules; 2018 Oct; 23(10):. PubMed ID: 30304796
[TBL] [Abstract][Full Text] [Related]
24. A simplified procedure for indole alkaloid extraction from Catharanthus roseus combined with a semi-synthetic production process for vinblastine.
Verma A; Laakso I; Seppänen-Laakso T; Huhtikangas A; Riekkola ML
Molecules; 2007 Jul; 12(7):1307-15. PubMed ID: 17909486
[TBL] [Abstract][Full Text] [Related]
25. ASSAY METHODS FOR SOME VINCA ROSEA ALKALOIDS. II.
JAKOVLJEVIC IM; SEAY LD; SHAFFER RW
J Pharm Sci; 1964 May; 53():553-7. PubMed ID: 14193893
[No Abstract] [Full Text] [Related]
26. Isolation of Catharanthus alkaloids by solid-phase extraction and semipreparative HPLC.
Naaranlahti T; Nordström M; Lapinjoki SP; Huhtikangas A; Lounasmaa M
J Chromatogr Sci; 1990 Apr; 28(4):173-4. PubMed ID: 2079546
[TBL] [Abstract][Full Text] [Related]
27. Vindoline and 16-demethoxyvindoline: two catharanthus-derived alkaloids.
Ruszkowska J; Chrobak R; Maurin JK; Czarnocki Z
Acta Crystallogr C; 2004 May; 60(Pt 5):o377-80. PubMed ID: 15131398
[TBL] [Abstract][Full Text] [Related]
28. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity of Vinca minor.
Khanavi M; Pourmoslemi S; Farahanikia B; Hadjiakhoondi A; Ostad SN
Pharm Biol; 2010 Jan; 48(1):96-100. PubMed ID: 20645762
[TBL] [Abstract][Full Text] [Related]
30. Selective deoxygenation of leurosine: concise access to anhydrovinblastine.
Hardouin C; Doris E; Rousseau B; Mioskowski C
J Org Chem; 2002 Sep; 67(18):6571-4. PubMed ID: 12201787
[TBL] [Abstract][Full Text] [Related]
31. Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
JOHNSON IS; WRIGHT HF; SVOBODA GH; VLANTIS J
Cancer Res; 1960 Aug; 20():1016-22. PubMed ID: 14407465
[No Abstract] [Full Text] [Related]
32. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
33. [Distribution and accumulation of vindoline, catharanthine and vinblastine in Catharanthus roseus cultivated in China].
Yu J; Yuan S; Pang H; Zhang X; Jia X; Tang Z; Zu Y
Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(23):3093-6. PubMed ID: 21355225
[TBL] [Abstract][Full Text] [Related]
34. Vinca alkaloids XXXIII [1]. Microbiological conversions of vincaleukoblastine (VLB, vinblastine), an antitumor alkaloid from Vinca rosea. Linn.
Neuss N; Mallett GE; Brannon DR; Mabe JA; Horton HR; Huckstep LL
Helv Chim Acta; 1974; 57(6):1886-90. PubMed ID: 4465345
[No Abstract] [Full Text] [Related]
35. [New antitumor derivatives of vinblastine].
Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
Ngo QA; Nguyen le A; Vo NB; Nguyen TH; Roussi F; Nguyen TH; Nguyen VT
Bioorg Med Chem Lett; 2015 Dec; 25(23):5597-600. PubMed ID: 26522953
[TBL] [Abstract][Full Text] [Related]
37. Two new vinblastine-type N-oxide alkaloids from Catharanthus roseus.
Zhang WK; Xu JK; Tian HY; Wang L; Zhang XQ; Xiao XZ; Li P; Ye WC
Nat Prod Res; 2013 Oct; 27(20):1911-6. PubMed ID: 23621523
[TBL] [Abstract][Full Text] [Related]
38. Elaboration of simplified vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Thoret S; Guéritte F
Chem Biol Drug Des; 2010 Mar; 75(3):284-94. PubMed ID: 20659111
[TBL] [Abstract][Full Text] [Related]
39. From periwinkle to an enduring anticancer drug.
Faguet G
Lancet Oncol; 2021 Mar; 22(3):308. PubMed ID: 33662284
[No Abstract] [Full Text] [Related]
40. Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn.
HODES ME; ROHN RJ; BOND WH; YARDLEY J
Cancer Chemother Rep; 1963 Apr; 28():53-5. PubMed ID: 13963767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
